Olympus Global Executive Search and Recruiting Human Solutions For The Global Community

BioPharma

The top issues facing stakeholders in 2013 in these industries are a changing health care landscape, expiring patents and generic competition, pricing pressures, heightened regulatory scrutiny, expansion into emerging markets, increasing alliances and acquisitions, and a persistent economic slowdown. Global life sciences companies are feverishly working to adopt new business models designed to counter slowing sales growth and declining profitability, deliver better patient outcomes at lower cost, and position them for success in 2013 and beyond. The key to their success will be in hiring top Scientist's, R and D, Attorney, Management, Sales and Marketing, and Financial Professionals to meet these challenges.

In 2011 the global pharmaceuticals, biotechnology, and life sciences industry generated total revenues in excess of $1.1 trillion, representing a compound annual growth rate (CAGR) of 6.7 percent between 2007 and 2011.

Among specific market segments, pharmaceuticals accounted for $798 billion in market revenue and biotechnology accounted for $289 billion. The Americas region accounts for the largest share of the global market, representing 46 percent of total revenues.

Several global trends have affected the industry’s growth and remain favorable in the long term:

• Aging population, especially in the large markets (Americas and Europe). The growth rate for the world’s 65+ year-old population is projected to outpace that of the 0-4 year-old segment by 2020,3 thus increasing demand for life sciences industry products and services.

• Rising incidence of chronic diseases. As a result of changes in lifestyle and eating habits, people are becoming more prone to chronic diseases such as diabetes and hypertension which, in turn, are high risk factors for heart attack and stroke. The demand for and use of preventive drugs and medical devices and other assisted technologies like ehealth and mobile health are increasing, as a result.

• Opportunities in emerging markets. Companies increasingly are targeting growth in emerging markets as a way to offset stagnating growth in developed regions.

• Technological advancements and product innovation. The areas of biotechnology and biosimilars, combination devices, and “big data” analytics are particularly active. Healthcare Information Technology is expected to sky rocket as an industry niche.

• Health care reform provisions, including increases in government funding and broader insurance coverage. In particular, the extension of health insurance to more than 30 million uninsured U.S. citizens under the Patient Protection and Affordable Care Act (PPACA or ACA) in 2014 is estimated to increase demand across the entire life sciences and health care industry in that country.

Global activity in a number of geographic markets, and the resulting considerations for companies as they seek to grow future revenue and market share, including business portfolio evolution; regulatory landscape changes; and market and treatment practices will require continuous enhancement and changes in personnel at all levels. The challenges and opportunities emanating from each of these areas provides tremendous opportunity for both global and market-specific hiring.

OEXEC © 2012 PRIVACY POLICY

Office: 603-828-7162

Email: info@oexec.com